Perfil lipídico y alteraciones menstruales en mujeres que usan el anticonceptivo inyectable combinado mesigyna

hormonal contraception with long-acting hormonal injections represrnt an established alternative. this study was aimed at knowing the disturbances that mently-birth control injection combined with mesigyna scherring ag provoked over lipid metabolism and menstrual pattern, to investigate it, 75 non-pregnant women who wished to control their fertility were included in the study. total cholesterol, c-hdl, c-ldl, triglycerides and ipa were determined showing that c-hdl had a slightly increase-trend from the second year of the use of aics mesigyna, the lpa increased in the 16% of the total of patients. menstrual pattern had regularity in its cycle-81.3 % of the total of women at the end of the study- concluding that the use of aics mesigyna produces disturbances on menstrual cycle invariably, demonstrating its antiatherogenic role due to its metabolic effects over lipid profile.